The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of healthcare resource use and treatment among prostate cancer patients with and without DNA damage repair gene mutations.
 
Jinan Liu
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Aimee Near
Consulting or Advisory Role - Janssen (Inst)
 
Joseph A. Chiarappa
Employment - Bristol-Myers Squibb (I); Janssen; Merck
Stock and Other Ownership Interests - Bristol-Myers Squibb (I)
 
Keiko Wada
Consulting or Advisory Role - Janssen (Inst)
 
Jenny Tse
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - Janssen (Inst)
 
Chakkarin Burudpakdee
Consulting or Advisory Role - Janssen (Inst)
Research Funding - Janssen (Inst)
 
Ajay S. Behl
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Emmanuel S. Antonarakis
Honoraria - Astellas Pharma; AstraZeneca; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Medivation; Merck; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Medivation; Merck; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi